Associated Papers
Development of LB244, an Irreversible STING Antagonist.
Barasa L et al.
Journal of the American Chemical Society, 2023
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I et al.
The Journal of Allergy and Clinical Immunology, 2017
Select a paper to view details